Companies/Decibel Cannabis Company Inc.

Company profile

Decibel Cannabis Company Inc.

OTC: DBCCF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Calgary, ABReports USD

#370 of 1,394 Healthcare companies by revenue65th-percentile growth

EA Score

62C

FH 63DQ —GM 61SS 55

v0.1 · 45/100 weight · provisional

↑ return on assets, return on equity · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

$87.8M

Rev growth YoY (TTM)

+31.6%

Net income (FY)

-$2.1M

Employees

171

Market cap

$46.4M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$80.6M112.6M CAD2025

Net income-$2.1M-2.9M CAD2025

Operating income-$12.4M-17.4M CAD2025

Total assets$103.2M141.5M CAD2025

Liabilities$57.8M79.2M CAD2025

Equity$45.5M62.3M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$106.5k

FY18

$4.7M

FY19

$22.3M

FY20

$41.8M

FY21

$61.0M

FY22

$78.7M

FY23

$67.6M

FY24

$80.6M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Decibel Cannabis Company Inc. booked $80.6M in FY2025 revenue, growing 19% year over year — faster than most Healthcare companies we track, at a -2.6% net margin.

Peers · Healthcare

Vicapsys Life Sciences, Inc.——Horizon Space Acquisition II Corp.——Metagenomi, Inc. Common Stock39D INmune Bio, Inc.41D

Key facts

CEOBenjamin Sze

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersCalgary, AB

ExchangeOTC: DBCCF

Employees171

IPO date2019-01-09

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.